WELL HEALTH TECHNOLOGIES COR (WELL.CA) Stock Fundamental Analysis
TSX:WELL - Toronto Stock Exchange - CA94947L1022 - Common Stock - Currency: CAD
We assign a fundamental rating of 3 out of 10 to WELL. WELL was compared to 15 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of WELL have multiple concerns. WELL is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
WELL had negative earnings in the past year.
WELL had a positive operating cash flow in the past year.
In multiple years WELL reported negative net income over the last 5 years.
Of the past 5 years WELL 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.60%, WELL is in line with its industry, outperforming 53.33% of the companies in the same industry.
Looking at the Return On Equity, with a value of -3.48%, WELL is in line with its industry, outperforming 53.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.6% | ||
| ROE | -3.48% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WELL has a Gross Margin of 38.51%. This is comparable to the rest of the industry: WELL outperforms 53.33% of its industry peers.
WELL's Gross Margin has improved in the last couple of years.
WELL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 38.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
WELL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for WELL has been increased compared to 5 years ago.
The debt/assets ratio for WELL has been reduced compared to a year ago.
2.2 Solvency
WELL has an Altman-Z score of 1.15. This is a bad value and indicates that WELL is not financially healthy and even has some risk of bankruptcy.
WELL has a Altman-Z score of 1.15. This is comparable to the rest of the industry: WELL outperforms 53.33% of its industry peers.
WELL has a Debt/Equity ratio of 0.59. This is a neutral value indicating WELL is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.59, WELL is doing good in the industry, outperforming 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.15 |
ROIC/WACCN/A
WACC7.42%
2.3 Liquidity
WELL has a Current Ratio of 0.92. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
WELL has a better Current ratio (0.92) than 66.67% of its industry peers.
WELL has a Quick Ratio of 0.92. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.92, WELL is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
WELL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.00%.
WELL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.19%.
The Revenue has been growing by 94.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
Revenue 1Y (TTM)17.19%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%27.02%
3.2 Future
The Earnings Per Share is expected to grow by 15.87% on average over the next years. This is quite good.
Based on estimates for the next years, WELL will show a quite strong growth in Revenue. The Revenue will grow by 15.85% on average per year.
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y15.87%
Revenue Next Year42.77%
Revenue Next 2Y24.88%
Revenue Next 3Y18.84%
Revenue Next 5Y15.85%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
WELL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
WELL is valuated rather expensively with a Price/Forward Earnings ratio of 19.69.
WELL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. WELL is cheaper than 80.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.78. WELL is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 19.69 |
4.2 Price Multiples
WELL's Enterprise Value to EBITDA ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 37.78 |
4.3 Compensation for Growth
WELL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WELL's earnings are expected to grow with 30.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.38%
EPS Next 3Y30.92%
5. Dividend
5.1 Amount
WELL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL (8/13/2025, 7:00:00 PM)
5.02
+0.2 (+4.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.41%
Inst Owner ChangeN/A
Ins Owners8.56%
Ins Owner ChangeN/A
Market Cap1.27B
Analysts81.05
Price Target7.8 (55.38%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-661.05%
Min EPS beat(2)-1116.23%
Max EPS beat(2)-205.87%
EPS beat(4)1
Avg EPS beat(4)4130.26%
Min EPS beat(4)-3335.29%
Max EPS beat(4)21178.4%
EPS beat(8)2
Avg EPS beat(8)1642.24%
EPS beat(12)3
Avg EPS beat(12)973.71%
EPS beat(16)3
Avg EPS beat(16)622.27%
Revenue beat(2)1
Avg Revenue beat(2)-5.51%
Min Revenue beat(2)-12.61%
Max Revenue beat(2)1.59%
Revenue beat(4)2
Avg Revenue beat(4)-2.66%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.92%
Revenue beat(12)7
Avg Revenue beat(12)0.22%
Revenue beat(16)11
Avg Revenue beat(16)1.27%
PT rev (1m)0.23%
PT rev (3m)-2.72%
EPS NQ rev (1m)4.18%
EPS NQ rev (3m)138.11%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)24.92%
Revenue NY rev (1m)1.26%
Revenue NY rev (3m)1.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 19.69 | ||
| P/S | 1.29 | ||
| P/FCF | N/A | ||
| P/OCF | 101.75 | ||
| P/B | 1.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 37.78 |
EPS(TTM)-0.12
EYN/A
EPS(NY)0.26
Fwd EY5.08%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.05
OCFY0.98%
SpS3.88
BVpS3.3
TBVpS-1.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.6% | ||
| ROE | -3.48% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 38.51% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score3
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 11.42 | ||
| Cap/Depr | 26.64% | ||
| Cap/Sales | 2.04% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 28.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.15 |
F-Score3
WACC7.42%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y15.87%
Revenue 1Y (TTM)17.19%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%27.02%
Revenue Next Year42.77%
Revenue Next 2Y24.88%
Revenue Next 3Y18.84%
Revenue Next 5Y15.85%
EBIT growth 1Y-191.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year269.34%
EBIT Next 3Y60.62%
EBIT Next 5Y41.9%
FCF growth 1Y-110.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.54%
OCF growth 3Y-22.85%
OCF growth 5YN/A